ENZON PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Enzon Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Enzon Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 48.3 %, a 36.9% increase year-over-year.
  • Enzon Pharmaceuticals, Inc. annual Return On Equity for 2023 was 46.5 %.
  • Enzon Pharmaceuticals, Inc. annual Return On Equity for 2022 was -5.51 %, a 30.5% increase from 2021.
  • Enzon Pharmaceuticals, Inc. annual Return On Equity for 2021 was -7.92 %, a 63.9% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 48.3 +13 +36.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 51.5 +28.1 +120% Apr 1, 2024 Jun 30, 2024
Q1 2024 49.7 +40.1 +416% Jan 1, 2024 Mar 31, 2024
Q4 2023 46.5 +52 Oct 1, 2023 Dec 31, 2023
Q3 2023 35.3 +55.4 Jul 1, 2023 Sep 30, 2023
Q2 2023 23.3 +45 Apr 1, 2023 Jun 30, 2023
Q1 2023 9.63 +24.4 Jan 1, 2023 Mar 31, 2023
Q4 2022 -5.51 +2.42 +30.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -20.1 -10.1 -99.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -21.7 -8.58 -65.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -14.8 +2.16 +12.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -7.92 +14 +63.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -10.1 +10.2 +50.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -13.1 +4.86 +27.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -17 -5.66 -50.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -21.9 -11.1 -103% Oct 1, 2020 Dec 31, 2020
Q3 2020 -20.3 -74.8 -137% Jul 1, 2020 Sep 30, 2020
Q2 2020 -17.9 -68.7 -135% Apr 1, 2020 Jun 30, 2020
Q1 2020 -11.3 -64.2 -121% Jan 1, 2020 Mar 31, 2020
Q4 2019 -10.8 -68.5 -119% Oct 1, 2019 Dec 31, 2019
Q3 2019 54.5 +61.1 Jul 1, 2019 Sep 30, 2019
Q2 2019 50.8 +49.6 +4293% Apr 1, 2019 Jun 30, 2019
Q1 2019 53 +9.98 +23.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 57.7 +8.12 +16.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -6.58 -9.85 -301% Jul 1, 2018 Sep 30, 2018
Q2 2018 1.16 -6.78 -85.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 43 +55.6 Jan 1, 2018 Mar 31, 2018
Q4 2017 49.5 +55.8 Oct 1, 2017 Dec 31, 2017
Q3 2017 3.27 -76.7 -95.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 7.94 -62.7 -88.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -12.6 -100 -114% Jan 1, 2017 Mar 31, 2017
Q4 2016 -6.24 -102 -106% Oct 1, 2016 Dec 31, 2016
Q3 2016 80 +21.1 +35.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 70.6 -15.6 -18.1% Apr 1, 2016 Jun 30, 2016
Q1 2016 87.8 -7.47 -7.84% Jan 1, 2016 Mar 31, 2016
Q4 2015 96.2 -28.7 -23% Oct 1, 2015 Dec 31, 2015
Q3 2015 58.9 -109 -64.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 86.1 -91.8 -51.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 95.3 -88.5 -48.2% Jan 1, 2015 Mar 31, 2015
Q4 2014 125 +63.6 +104% Oct 1, 2014 Dec 31, 2014
Q3 2014 168 +152 +965% Jul 1, 2014 Sep 30, 2014
Q2 2014 178 +171 +2447% Apr 1, 2014 Jun 30, 2014
Q1 2014 184 +183 +35686% Jan 1, 2014 Mar 31, 2014
Q4 2013 61.3 +63 Oct 1, 2013 Dec 31, 2013
Q3 2013 15.8 +17.1 Jul 1, 2013 Sep 30, 2013
Q2 2013 6.99 +15.1 Apr 1, 2013 Jun 30, 2013
Q1 2013 0.51 +11.2 Jan 1, 2013 Mar 31, 2013
Q4 2012 -1.72 Oct 1, 2012 Dec 31, 2012
Q3 2012 -1.38 Jul 1, 2012 Sep 30, 2012
Q2 2012 -8.09 Apr 1, 2012 Jun 30, 2012
Q1 2012 -10.7 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.